Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP565802.RA9Vr6sJyI5ZX2LB4j55LfvtrqC0DBWFhas6vTav65USI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP565802.RA9Vr6sJyI5ZX2LB4j55LfvtrqC0DBWFhas6vTav65USI130_assertion type Assertion NP565802.RA9Vr6sJyI5ZX2LB4j55LfvtrqC0DBWFhas6vTav65USI130_head.
- NP565802.RA9Vr6sJyI5ZX2LB4j55LfvtrqC0DBWFhas6vTav65USI130_assertion description "[While patients with ECE-1 overexpressing tumours had more frequent disease recurrence (P = 0.03), NEP overexpression correlated with improved disease-free survival (DFS) (P = 0.023) and less frequent metastasis (P = 0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565802.RA9Vr6sJyI5ZX2LB4j55LfvtrqC0DBWFhas6vTav65USI130_provenance.
- NP565802.RA9Vr6sJyI5ZX2LB4j55LfvtrqC0DBWFhas6vTav65USI130_assertion evidence source_evidence_literature NP565802.RA9Vr6sJyI5ZX2LB4j55LfvtrqC0DBWFhas6vTav65USI130_provenance.
- NP565802.RA9Vr6sJyI5ZX2LB4j55LfvtrqC0DBWFhas6vTav65USI130_assertion SIO_000772 17295044 NP565802.RA9Vr6sJyI5ZX2LB4j55LfvtrqC0DBWFhas6vTav65USI130_provenance.
- NP565802.RA9Vr6sJyI5ZX2LB4j55LfvtrqC0DBWFhas6vTav65USI130_assertion wasDerivedFrom befree-20140225 NP565802.RA9Vr6sJyI5ZX2LB4j55LfvtrqC0DBWFhas6vTav65USI130_provenance.
- NP565802.RA9Vr6sJyI5ZX2LB4j55LfvtrqC0DBWFhas6vTav65USI130_assertion wasGeneratedBy ECO_0000203 NP565802.RA9Vr6sJyI5ZX2LB4j55LfvtrqC0DBWFhas6vTav65USI130_provenance.